Company: ICUI
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0000883984-25-000016
Chunk: 67

Company: ICU MEDICAL INC/DE
Filing Date: 2025-05-08
Form: 10-Q
Item: Item 1
Chunk 67
---
 actions, including, without limitation, the acceleration of all amounts due and the termination of commitments under the Senior Secured Credit Facilities.The carrying values of our long-term debt consist of the following (in thousands):

32

ICU MEDICAL, INC. AND SUBSIDIARIESNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Effective Interest RateAs of March 31, 2025Effective Interest RateAs of December 31, 2024Senior Secured Credit Facilities:Term Loan A — principal7.17 %$759,688 8.03 %$770,313 Term Loan B — principal7.51 %789,500 8.38 %826,625 Revolving Credit Facility — principal— %— — %— Less unamortized debt issuance costs(1)(12,810)(14,080)Total carrying value of long-term debt1,536,378 1,582,858 Less current portion of long-term debt47,813 51,000 Long-term debt, net$1,488,565 $1,531,858 _______________________________(1)    Comprised of $5.3 million and $7.5 million relating to the Term Loan A and the Term Loan B, respectively, as of March 31, 2025.As of March 31, 2025, the aggregate amount of principal repayments of our long-term debt (including any current portion) for each of the next five years and thereafter is approximately (in thousands):Remainder of 2025$31,875 202663,750 2027664,063 2028— 2029789,500 2030— Total$1,549,188 The following table presents the total interest expense related to our long-term debt (in thousands):Three months ended March 31,20252024Contractual interest$26,888 $32,276 Amortization of debt issuance costs1,699 1,708 Commitment fee — Revolving Credit Facility375 379 Total long-term debt-related interest expense$28,962 $34,363 We currently hedge against the contractual interest expense on our long-term debt (see Note 9: Derivatives and Hedging Activities).

Note 19:  Stockholders' Equity

Treasury Stock    In August 2019, our Board approved